Members of genus Xenorhabdus are symbiotically associated with entomopathogenic nematodes of genus Steinernema. Herein, we describe the isolation and purification of four novel metabolites, xenocyloins G-J (1-4), from liquid cultures of Xenorhabdus bovienii SN52 by extensive column chromatography and semi-preparative HPLC. Chemical structures of the xenocyloin derivatives were determined based on comprehensive NMR spectra and HR-ESI-MS analyses. All compounds exhibited significant collagen-induced anti-platelet aggregation activities, among which xenocyloin H (2) exhibited the strongest activity with an inhibition rate of 96.0 ± 0.1% at a concentration of 50 μM. The xenocyloin G (1) and H (2) exhibited anti-platelet activities with IC 50 values which were 31.7 ± 4.4 μM and 27.5 ± 3.5 μM respectively; whilst under similar conditions the IC 50 value for aspirin was 289.5 ± 15.7 μM, nearly ten times less than 1 and 2.
Gram-negative bacterial strains of genus Xenorhabdus, which are members of family Enterobactetiaceae, engage in a mutualistic association with soil-dwelling entomopathogenic nematodes of genus Steinernema [1] [2] [3] . Those nematodes that carry symbiotic bacteria enter insect larvae through natural openings, and then release bacteria from their intestine into the insect host [4] . Subsequently, the bacteria produce inhibitors of the insect immune system and insecticidal proteins that can kill the insect host [5] [6] [7] . Furthermore, strains of Xenorhabdus spp. can produce diverse secondary metabolites that exhibit a broad spectrum of effects, including insecticidal, antibacterial, and antifungal bioactivities [1, [8] [9] [10] [11] .
Previously, we identified five xenocyloins, including one novel compound, in liquid cultures of Xenorhabdus bovienii SN52 [12] . We have continued to investigate the chemical composition of this species. Herein, we report the isolation and structural elucidation of four novel xenocyloins, classified as G-J (1) (2) (3) (4) , from liquid cultures of X. bovienii SN52. We also describe the anti-platelet aggregation activities of these compounds. Anti-platelet aggregation was widely used in research the targeting components or chemicals with effective functions [13] .
Compound 1 was isolated as a colorless oil and has the molecular formula C 15 H 19 NO 2 , as determined based on 13 Analysis of 13 C NMR and HSQC spectra revealed 15 carbons that corresponded to three methyl carbons, one methylene carbon, seven the presence of a 2-hydroxy-3-oxo-4-methylpentyl group in the structure. Linkage of this group to C-3 of the 1-methylindole group was further confirmed by HMBC correlations between δ H 6.98 (H-2) and δ C 29.9 (C-10). A similar optical rotation value of compound 1 ([α] 25 D : +52.5) with xenocyloin A ([α] 25 D : +86.0) [14, 15] supported a S configuration of C-11 in 1. Thus, the structure of 1 was identified as 3-(11-hydroxy-12-oxo-13-methylpentyl)-1methylindole, which we named xenocyloin G (Figure 1 ).
Compound 2 was obtained as a colorless oil and its molecular formula was determined to be C 17 H 21 NO 3 by HRESIMS (molecular ion at m/z 288.1606 [M + H] + , calcd. for 288.1599). Analysis of 1 H and 13 C NMR spectra of compounds 1 and 2 indicated that compound 2 was also a xenocyloin-derivative, which was similar to 1 ( Table 1 ). The only difference that we noted was the replacement of a hydroxyl group (11-OH) in 1 by an acetoxyl group in 2, which was confirmed by the HMBC correlation of δ H 5.48 (H-11) to an ester carbonyl carbon at δ C 170.3 (C-1) . A similar optical rotation value of compound 2 ([α] 25 D : +54.0) with compound 1 supported the configuration of C-11 in 2. Therefore, the structure of 2 was elucidated as 3-(11-acetoxyl-12-oxo-13-methylpentyl)-1-methylindole, which we named xenocyloin H ( Figure 1 ). . Inspection of NMR spectra data led to the conclusion that 3 was another xenocyloin derivative that had a 1-methylindole group. NMR spectra of 3 ( Table 2) were very similar to those of 1, except for one methylene resonance at δ H 2.41 (2H, d, J = 6.9 Hz) and δ C 47.2 in 3. In the HMBC spectrum of 3, methylene proton signals at δ H 2.41 showed correlations to one ketone carbonyl carbon (δ C 211.7, C-12), one methine carbon (δ C 24.4, C-14), and two methyl carbons (δ C 22.5, C×2, C-15 and C-17), which suggested that the methylene group was connected to C-12. Compare the optical rotation value of compound 3 ([α] 25 D : +66.7) with (+)-sattazolin ([α] 25 D : +52.0) [16] supported the configuration of C-11 in 3. Therefore, the structure of 3 was confirmed as 3-(11-hydroxy-12-oxo-14-methylhexyl)-1methylindole, which we named xenocyloin I (Figure 1 ).
The HRESIMS (found: m/z 260.1649; calcd for 260.1650) and 13 C NMR spectra of 4 indicated a molecular formula of C 16 H 21 NO 2 , which was identical to that of 3. The close resemblance between the NMR spectra of 3 and 4 indicated that 3 was an isomer of 4 ( Table  2 ). The major difference was that the methylene carbon (C-13) at δ C 47.2 in 3 was shifted up-field to δ C 27.0 in 4, while the methine carbon (C-14) at δ C 24.4 in 3 was shifted down-field to δ C 43.0 in 4.
In the HMBC spectrum of 4, one doublet methyl proton signal (δ H 1.02) and one triplet methyl proton signal (δ H 0.89) exhibited correlations to δ C 27.0 and 43.0, respectively, suggesting that the C-17 was connected to C-13 in 4. The optical rotation value of 4 ([α] 25 D : +75.0) was similar to that of xenocyloin B ([α] 25 D : +87.0) [14, 15] , indicating 4 had the same configuration as xenocyloin B. Therefore, the structure of 4 was determined to be 3-(11-hydroxy-12-oxo-13-methylhexyl)-1-methylindole, which we named xenocyloin J (Figure 1 ).
Anti-platelet aggregation assay:
Platelet aggregation assays were carried out using human platelet-rich plasma (PRP). Aggregation was initiated by the addition of collagen (10 μg/mL) and the reaction was monitored turbidimetrically on a four-channel aggregometer. Xenocyloins G-J (1-4) exhibited significant antiplatelet aggregation activities at a concentration of 50 M, with inhibition rates ranging from 52.9 ± 5.5% to 96.0 ± 0.1%. Among the compounds tested, xenocyloin H (2) showed the strongest antiplatelet aggregation activity with an inhibition rate of 96.0 ± 0.1%.The xenocyloins G (1) and H (2) exhibited anti-platelet activities with IC 50 values which were 31.7 ± 4.4 μM and 27.5 ± 3.5 μM respectively, meanwhile under similar conditions the IC 50 value for aspirin was 289.5 ± 15.7 μM, nearly ten times less than 1 and 2.
In this manuscript, four novel metabolites, xenocyloins G-J (1-4) , derived from the entomopathogenic bacteria X. bovienii SN52, were described. All of these compounds exhibited anti-platelet aggregation activities that could be induced by collagen. These findings expand the chemical diversity of X. bovienii SN52 metabolites and provide a foundation for the future development and utilization of this bacterium.
Experimental
Strain cultivation: Xenorhabdus bovienii SN52 was isolated in the Liaoning province of China from the entomopathogenic nematode Steinernema sp. It was identified by 16S rDNA sequence analysis and maintained in culture at the Plant Protection College of Shenyang Agricultural University [17] .
Purification of special metabolites:
MeOH extracts were concentrated to dryness on a rotary evaporator, yielding a dark brown oily residue and an amorphous precipitate. The extract was redissolved in H 2 O and dichloromethane 1:1 (v/v; 400 mL), and was consecutively extracted with dichloromethane to obtain a dichloromethane extract. The resulting dichloromethane extract (brown oil, 20 g) was subjected to siliconegel column chromatography and elution with petroleum ether-ethyl acetate (100:4, 100:8, 100:16 and 1:1) to yield four fractions (Fractions 1-4). Fraction 3 was repeatedly purified by silicone gel column chromatography with petroleum ether-ethyl acetate (100:5 and 100:10) as the solvent system to yield subfractions 3a and 3b. Finally, subfraction 3a was successively purified using semipreparative HPLC and eluted with MeOH in H 2 O (60%; UV, 254 nm) to yield 4 (colorless oil, 6.6 mg). Subfraction 3b was isolated by silicone gel column chromatography using petroleum etherdichloromethane-methanol (2:1:1) and petroleum ether-ethyl acetate (100:5) as the solvent system. Subfraction 3b was then purified by semi-preparative HPLC using MeOH in H 2 O (70%) to yield 2 (colorless oil, 63 mg). Fraction 4 was divided into two parts (subfractions 4a and 4b) using silicone gel column chromatography and eluted with petroleum ether-ethyl acetate-dichloromethanemethanol (2:1:1). Subfractions 4a and 4b were then purified by semi-preparative HPLC and eluted with MeOH in H 2 O (63%) and acetonitrile in H 2 O (42%) to yield pure 1 (colorless oil, 20.5 mg) and 3 (colorless oil, 7.6 mg), respectively.
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Analysis of metabolites:
Both 1D and 2D NMR spectra were recorded on a Bruker AVANCE 600 spectrometer. Chemical shifts and coupling constants were reported in parts per million and hertz, respectively. Samples were dissolved in CDCl 3 . MS analyses were carried out on an Agilent 6540 series instrument. 
Platelet aggregation assay:
In vitro platelet aggregation assays were carried out using the turbidimetric method with minor modifications [18] . Collagen was obtained from HYPHEN BioMed. Human platelets were obtained from the Blood Center of Jiangsu Province in China. Platelet concentrations were adjusted using Tyrose's buffer to 3×10 8 platelets/mL. A volume of 270 μL plateletrich plasma (PRP) was preincubated at 37°C for 5 min in a cuvette with 20 μL sample or vehicle (saline). Platelet aggregation was then induced by the addition of 10 μL collagen (10 μg/mL). The maximum platelet aggregation rate was determined within 5 min with continuous stirring at 37°C using a four-channel aggregometer (Beijing Steellex Science Instrument Company, China). The concentration at which each compound caused 50% inhibition (IC 50 ) was calculated (n=4).
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